TY - JOUR
T1 - Ameliorative effect of Arabic gum Acacia and mori extracts in streptozotocin-induced diabetic rats
T2 - implications of Cas-3 and TGF-β
AU - El-Shafei, R. A.
AU - El-Adl, M. A.
AU - Ali, H. S.
AU - Nomier, Y.
N1 - Publisher Copyright:
© 2023 Verduci Editore s.r.l. All rights reserved.
PY - 2023/4
Y1 - 2023/4
N2 - OBJECTIVE: Arabic gum Acacia (AG) is rich in fiber which improves lipid metabolism besides its antioxidant effect. Folium mori (FM) is a widely used herb due to its immunomodulatory, antimicrobial, and antioxidant activity. In the current study, we explore the antidiabetic, anti-inflammatory, as well as antioxidant activities of AG and FM in Streptozotocin (STZ), induced diabetic rats. MATERIALS AND METHODS: STZ diabetic rats were orally administrated with metformin and/or a combination of AG and FM for 4 weeks. Glycemic levels, Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), cholesterol, triglycerides, urea, and creatinine were determined. Malondialdehyde (MDA), glutathione peroxidase (GPx), and Superoxide dismutase (SOD) were also evaluated. Gene expression and profile as well as immunohistopathological were also evaluated. RESULTS: The results elicited no toxicological profile of both AG and FM. Plasma glucose level was decreased starting from 1st week to 4th week; besides, there was an improvement in glycated hemoglobin, insulin, and fructosamine. Liver and kidney damage markers were decreased in both AG and FM-treated rats. A significant increase in the antioxidant defense system and a decrease in oxidative stress markers were also observed. Gene expression analysis in brain tissues revealed a significant decrease in Interleukin beta 1 (IL-β1), Caspase 3 (Cas-3), and Transforming growth factor beta (TGF-β). CONCLUSIONS: Oral treatment of metformin with AG and FM in STZ-injected rats could ameliorate protective pathways and can be one of the promising oral anti-diabetic herbal agents.
AB - OBJECTIVE: Arabic gum Acacia (AG) is rich in fiber which improves lipid metabolism besides its antioxidant effect. Folium mori (FM) is a widely used herb due to its immunomodulatory, antimicrobial, and antioxidant activity. In the current study, we explore the antidiabetic, anti-inflammatory, as well as antioxidant activities of AG and FM in Streptozotocin (STZ), induced diabetic rats. MATERIALS AND METHODS: STZ diabetic rats were orally administrated with metformin and/or a combination of AG and FM for 4 weeks. Glycemic levels, Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), cholesterol, triglycerides, urea, and creatinine were determined. Malondialdehyde (MDA), glutathione peroxidase (GPx), and Superoxide dismutase (SOD) were also evaluated. Gene expression and profile as well as immunohistopathological were also evaluated. RESULTS: The results elicited no toxicological profile of both AG and FM. Plasma glucose level was decreased starting from 1st week to 4th week; besides, there was an improvement in glycated hemoglobin, insulin, and fructosamine. Liver and kidney damage markers were decreased in both AG and FM-treated rats. A significant increase in the antioxidant defense system and a decrease in oxidative stress markers were also observed. Gene expression analysis in brain tissues revealed a significant decrease in Interleukin beta 1 (IL-β1), Caspase 3 (Cas-3), and Transforming growth factor beta (TGF-β). CONCLUSIONS: Oral treatment of metformin with AG and FM in STZ-injected rats could ameliorate protective pathways and can be one of the promising oral anti-diabetic herbal agents.
KW - Arabic gum
KW - Diabetes
KW - Folium mori
KW - Metformin
KW - Streptozotocin
KW - Streptozocin/pharmacology
KW - Caspase 3/metabolism
KW - Gum Arabic/pharmacology
KW - Diabetes Mellitus, Experimental/chemically induced
KW - Antioxidants/pharmacology
KW - Transforming Growth Factor beta/metabolism
KW - Oxidative Stress
KW - Metformin/pharmacology
KW - Rats
KW - Acacia/metabolism
KW - Blood Glucose/analysis
KW - Animals
KW - Plant Extracts/pharmacology
KW - Hypoglycemic Agents/pharmacology
UR - http://www.scopus.com/inward/record.url?scp=85152977104&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85152977104&partnerID=8YFLogxK
U2 - 10.26355/eurrev_202304_31915
DO - 10.26355/eurrev_202304_31915
M3 - Article
C2 - 37070884
AN - SCOPUS:85152977104
SN - 1128-3602
VL - 27
SP - 2845
EP - 2857
JO - European Review for Medical and Pharmacological Sciences
JF - European Review for Medical and Pharmacological Sciences
IS - 7
ER -